Along the road to improving diabetes care, both doctors and scientists have disagreed about which treatments are best. Now, there is disagreement about the safety of one of the most common diabetes drugs.

Doctors have to carefully watch their diabetes patients for other serious health problems like kidney disease and heart disease. Now, it seems doctors should keep an eye out for blood cancers as well.

About 80 percent of people diagnosed with pancreatic cancer also have diabetes. While it's known that the two diseases are linked, the exact nature of this association remains unclear.

Back in 2005, Scottish researchers found surprisingly low rates of cancer among diabetes patients taking metformin , one of the most commonly used drugs for treating type 2 diabetes. Now, we may know why this happens.

More and more research is showing a link between breast cancer and diabetes. Yet, only a handful of studies have looked at the relationship between cancer drugs and the risk of diabetes.

There have been huge strides in the fight against diabetes over the past decade. Patients now have more treatment and drug options than they ever did before. Yet, some of these drugs may not be entirely safe.

They are two of the newer drugs used to treat Type 2 diabetes. They are effective in lowering blood sugar. New findings, though, cast doubt on the safety of these medications.

The younger a smoker is that decides to quit, obviously the better for their health. Women in their golden years can receive immediate benefits from quitting.

If you've been taking Actos or Takeda for more than a year to control your type 2 diabetes, you will want to be in touch with your family physician or endocrinologist. A link with bladder cancer has been discovered.

Actos and Competact, two top-selling type 2 diabetes drugs, have been pulled off the markets in France and Germany following studies linking the medications to bladder cancer.